NEW
YORK, Oct. 24, 2024 /PRNewswire/ -- Baird
Medical, (NASDAQ: BDMD) a global leader in minimally invasive
microwave ablation (MWA) technology, successfully participated in
the prestigious 2024 American College of Surgeons (ACS) Clinical
Congress held at the renowned Moscone Center in San Francisco. This year's congress attracted
over 10,000 attendees, including 7,000 surgeons from around the
world, making it one of the largest surgical events globally.
Baird Medical shines at ACS Congress with
innovative MWA demos.
The ACS, established in 1913, is the world's largest and
most influential organization for surgeons, boasting more than
90,000 members across 144 countries. The annual Clinical Congress
serves as a key platform for discussing surgical advancements,
exploring new technologies, and fostering collaboration within the
medical community.
On October 20, Baird Medical
showcased its cutting-edge microwave ablation devices at Booth
1061, highlighting their applications in treating thyroid nodules,
breast disease, liver cancer, and uterine fibroids. Baird's
innovative MWA technology, which has been adopted by top
institutions such as Columbia
University, Weill Cornell, and Tulane
University, drew significant interest from surgeons and
medical professionals across multiple specialties.
The live demonstrations of Baird's MWA technology were a
standout feature of the exhibition. Surgeons from the Middle East, South
America, and the United
States had the opportunity to experience hands-on
simulations, showcasing the precision and efficiency of MWA in
treating benign tumors and other conditions.
Throughout the congress, Baird Medical actively engaged with key
thought leaders and participated in a range of panel discussions,
including sessions on "Emerging Ablative Therapies for Breast
Cancer" and "Endocrine Surgery." These panels provided valuable
insights into the future of ablation techniques and reinforced the
growing interest in minimally invasive solutions for various
conditions.
A major highlight of the event was reuniting with prominent
leaders in the field of endocrine surgery and interventional
endocrinology from top institutions. These collaborative
discussions further strengthened Baird's mission to enhance patient
care through innovative technology and fostered ongoing
relationships with experts who have been instrumental in advancing
the use of MWA in clinical practice.
As the ACS Clinical Congress ended, Baird Medical reaffirmed its
commitment to expanding its presence in the U.S. and international
markets. The company's participation in the congress showcased its
advanced MWA technology and provided an invaluable opportunity to
network with leading surgeons and explore future
collaborations.
About the ACS Clinical Congress
The American College of Surgeons (ACS) Clinical Congress is one of
the world's largest gatherings of surgeons, dedicated to sharing
advancements in surgical techniques and improving patient care. The
congress brings together thousands of professionals from across the
globe to exchange knowledge and foster collaborations that advance
clinical practices.
About Baird Medical
Baird Medical is a leading provider of minimally invasive microwave
ablation (MWA) technology, offering advanced treatment solutions
for conditions such as thyroid nodules, breast disease, uterine
fibroids, and liver cancer. A publicly traded company on NASDAQ,
Baird Medical is dedicated to enhancing patient care through
precision, efficiency, and safety in its innovative medical
devices. For more information, please visit
https://bairdmed.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/baird-medical-proudly-invited-to-showcase-microwave-ablation-technology-at-the-acs-clinical-congress-302285609.html
SOURCE Baird Medical LLC
